Ticker
ENGN
Asset Class
Equity
Assets Under Management
12.34M
Holdings
10+
enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company in Canada. The company develops genetic medicines to help patients suffering from bladder cancer.
Loading chart…